Delivery Order SPE2DB20D2014-SPE2DB25FC60R
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,545.30 for Trulicity 1.5 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction under AmerisourceBergen's broader federal contract portfolio. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $1,383.93 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 1, 2025, with completion expected by August 4, 2025. This firm fixed-price contract, issued without set-aside designation, leverages AmerisourceBergen's established relationship with DLA through competitive procurement procedures. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens valued at $1,174.39 with a firm fixed price structure. This competitively awarded, non-set-aside contract became effective on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL). This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a $3,648.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price contract, which is part of a larger Indefinite Delivery Contract vehicle, represents a routine pharmaceutical procurement supporting federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 24, 2025, with completion scheduled for July 25, 2025. The award is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens valued at $5,236.50 on July 29, 2025, with completion scheduled for July 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's distribution facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,756.58 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 23, 2025, with completion scheduled for July 24, 2025. This firm fixed-price contract is a non-set-aside competitive award and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL units. This firm fixed-price contract, valued at $1,734.90, represents a competitive award with no set-aside designation and is scheduled for completion by July 23, 2025. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is executed...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC60RDelivery Order
The Defense Logistics Agency awarded a $6,038.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded contract, issued without set-aside designation, represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities to military healthcare systems and other federal customers. AmerisourceBergen's position as a primary pharmaceutical distributor for federal medical procurement, combined with its demonstrated capability to manage both small-value and substantial orders competitively, supports its continued role in the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/30/25 |